Moderna and Pfizer's Second-Gen Coronavirus Vaccines: What Investors Need to Know

Moderna and Pfizer's Second-Gen Coronavirus Vaccines: What Investors Need to Know·Motley Fool
In this article:

Right now, the vaccines from Moderna (NASDAQ: MRNA) and the joint effort of Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) appear to be at least partially effective against the variants. This could be significant for investors: The new vaccines might just lead to significant differences in revenues for Moderna, Pfizer, and BioNTech. Moderna is examining three different booster shot strategies, including a variant-specific booster, a third dose of its current candidate, and a multivalent booster that combines its current candidate with variant-specific material.

Advertisement